Skip to main content

Table 1 (abstract A31). Characteristics of the study population

From: Abstracts from the 24th Congress of the Italian Society of Cystic Fibrosis and the 14th National Congress of Cystic Fibrosis Italian Society

Patients (n°)

22

  

Sex (M/F)

11/11

  

Pulmonary exacerbation (n°)

40

  

Pulmonary exacerbation/patients

1.8

  

Pancreatic sufficiency (n°)

1 (4.5%)

  

MRSA chronic pulmonary infection (n°)

4 (18%)

  

PA chronic pulmonary infection (n°)

13 (59%)

  

Other infection (MSSA, H.influenzae)

5 (23%)

  

Mean age at admission (years)

11.47 (1-21)

  

Mean duration of hospitalization (days)

15 ±2

  
 

Before therapy

After therapy

P-value

Mean serum SAA (ng/ml) (range)

166.5 (2-937)

9.9 (<6-74)

<0.05

Mean serum CRP (mg/l) (range)

21.65 (<2.9-139)

4.7 (<2.9-18)

<0.05

  1. MRSA: methicillin resistant staphylococcus aureus; PA: Pseudomonas aeruginosa; MSSA: methicillin sensitive staphylococcus aureus